Clinical trial
Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in…
NCT00229333 · Sheba Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00229333 |
|---|---|
| Title | Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia |
| Official title | Exploratory Study to Assess the Efficacy of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia and Mixed Vascular and Alzheimer's Dementia |
| Lead sponsor | Sheba Medical Center, Other |
| Collaborators | H. Lundbeck A/S Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depressive Syndrome |
| Intervention type | Drug |
| Interventions | Escitalopram |
| Enrollment | 40 |
| Start date | Dec 1, 2004 |
| First posted | Sep 29, 2005 |
| Last update posted | Aug 29, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: